DOCSLIB.ORG

YIPF5 Mutations Cause Neonatal Diabetes and Microcephaly: Progress for Precision Medicine and Mechanistic Understanding

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
YIPF5 Mutations Cause Neonatal Diabetes and Microcephaly: Progress for Precision Medicine and Mechanistic Understanding YIPF5 mutations cause neonatal diabetes and microcephaly: progress for precision medicine and mechanistic understanding Toni I. Pollin, Simeon I. Taylor J Clin Invest. 2020. https://doi.org/10.1172/JCI142364. Commentary Identifying genes that result in monogenic diabetes can provide insights that can build a scientific foundation for precision medicine. At present, nearly 20% of neonatal diabetes cases have unknown causes. In this issue of the JCI, De Franco and Lytrivi et al. sequenced the genome of two probands with a rare neonatal diabetes subtype that also associated with microcephaly and epilepsy. The authors revealed mutations in the YIPF5 gene. YIPF5 resides in the Golgi apparatus and is thought to play a critical role in vesicular trafficking. Notably, disrupting YIPF5 in β cell–based models induced ER stress signaling and resulted in the accumulation of intracellular proinsulin. We believe that utilizing registries and biobanks to reveal other monogenic atypical forms of diabetes is an important approach to gaining insight and suggest that an insulin sensitizer may alleviate ER stress associated with YIPF5 disruption by decreasing the demand for insulin secretion. Find the latest version: https://jci.me/142364/pdf The Journal of Clinical Investigation COMMENTARY YIPF5 mutations cause neonatal diabetes and microcephaly: progress for precision medicine and mechanistic understanding Toni I. Pollin and Simeon I. Taylor Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA. were described in the 1970s (11, 12), and shown in the 1980s to be caused by muta- Identifying genes that result in monogenic diabetes can provide insights that tions in the insulin receptor gene (13–15). can build a scientific foundation for precision medicine. At present, nearly 20% of neonatal diabetes cases have unknown causes. In this issue of the Precision medicine JCI, De Franco and Lytrivi et al. sequenced the genome of two probands with opportunities a rare neonatal diabetes subtype that also associated with microcephaly and As emphasized by Hattersley and Patel epilepsy. The authors revealed mutations in the YIPF5 gene. YIPF5 resides (16), precision medicine has at least three in the Golgi apparatus and is thought to play a critical role in vesicular important benefits: (a) optimizing choice trafficking. Notably, disrupting YIPF5 in β cell–based models induced ER of medications, (b) enhanced ability to stress signaling and resulted in the accumulation of intracellular proinsulin. predict patients’ clinical courses, and (c) We believe that utilizing registries and biobanks to reveal other monogenic enabling early diagnosis through genetic atypical forms of diabetes is an important approach to gaining insight and technology. For example, nine years after suggest that an insulin sensitizer may alleviate ER stress associated with the identification of HNF1A as the MODY3 YIPF5 disruption by decreasing the demand for insulin secretion. gene, Hattersley and colleagues reported that individuals harboring HNF1A muta- tions and previously diagnosed with type 1 diabetes could switch from insulin injec- tions to low-dose oral sulfonylureas with- Monogenic diabetes genes by a lower degree of severity and the lack out loss of glycemic control (17). As this Precision medicine for diabetes is often of a requirement for insulin treatment. group at the University of Exeter led the said to be on the horizon. However, as The age of onset sets MODY apart from way in implementation, they and others noted in the recent joint American Dia- maturity-onset diabetes (now known as continued to discover monogenic diabetes betes Association (ADA)/European Asso- type 2 diabetes). MODY’s distinct Mende- genes. They made another breakthrough ciation for the Study of Diabetes (EASD) lian inheritance pattern sets it apart from discovery in 2004 by finding that 10 of Precision Medicine in Diabetes Initiative both types (3). 29 patients with the rare condition of neo- (PMDI) consensus report (1), in some The first three MODY genes were natal diabetes had activating mutations instances the horizon stretches back sev- identified as GCK (MODY2) in 1992 (4), in the KCNJ11 gene encoding the Kir6.2 eral decades. The existence of monogenic HNF4A (MODY1) in 1996 (5), and HNF1A subunit of the ATP-sensitive potassium forms of diabetes has long been known. (MODY3) in 1996 (6). A separate stream of channel (18). Just two years later they In 1974, Tattersall noted “mild familial research identified several monogenic dia- established that high-dose oral sulfony- diabetes with dominant inheritance” (2) betes syndromes characterized by severe lureas, instead of insulin injections, could in some families, and shortly thereafter insulin resistance. Although generalized successfully treat most of the patients with Tattersall together with Fajans coined lipodystrophy was described in the 1950s (7, KCNJ11 mutations (19). the term “maturity onset diabetes of the 8), it would take another forty-plus years to Fast-forward to today. De Franco and young (MODY).” MODY is distinguished identity two disease genes: AGPAT2 (9) and Lytrivi et al. (20) note in this issue of the clinically from classical juvenile-onset BSCL2 (10). In addition, several syndromes JCI that, prior to the current work, 30 neo- diabetes (now known as type 1 diabetes) of insulin-resistant diabetes syndromes natal diabetes genes had been identified — accounting for 82% of cases. Variants in some of these genes cause extrapancreatic Related Article: https://doi.org/10.1172/JCI141455 syndromic features, including neurolog- ical features with 11 of the genes. Identi- Conflict of interest: TIP receives partial research funding from a grant to the University of Maryland, Baltimore, by the fication of these rarer neonatal subtypes Regeneron Genetics Center. SIT serves as a paid consultant to Ionis Pharmaceuticals and is listed as an inventor on a yields precision medicine opportunities methods of use patent, titled “Use of leptin for treating human lipoatrophy and method of determining predisposition to as well; for example, FOXP3 mutations said treatment” (US 7,183,254 B2). Copyright: © 2020, American Society for Clinical Investigation. in neonatal diabetes reveal an underlying Reference information: J Clin Invest. https://doi.org/10.1172/JCI142364. polyendocrinopathy in which early treat- jci.org 1 COMMENTARY The Journal of Clinical Investigation ment with a bone marrow transplant can group, based at the University of Maryland two Rab-like GTPases as bait (Ypt1 and prevent otherwise often fatal gastrointes- School of Medicine, brings experts togeth- Ypt31) (25). In a follow-up two-hybrid tinal enteropathy (21). Precision medicine er to pool clinical data and to develop and screen, Yif1p was discovered as a Yip1p-in- has also led to an innovative treatment for implement disease- as well as gene-spe- teracting protein (26). Functional studies generalized lipodystrophy. Metreleptin cific variant classification rules (24). demonstrated that Yip1p and Yif1p form provides life-changing efficacy to patients Exome sequencing is challenging a heterodimer, which plays a critical role with generalized lipodystrophy (22) and because of the volume of data generated in vesicle trafficking from the endoplas- has received regulatory approval as a new and consequent magnified difficulty of mic reticulum (ER) to the cis-Golgi; Rab- drug specifically indicated to treat that distinguishing benign from causal vari- like proteins play a downstream role in orphan disease. ation. The risk of false positives is high. the process (26). Seven members of the The Exeter group has a strong diag- One must go about it in a both systematic Yip1 domain family have been identified nostic program for monogenic diabetes. and open-minded, exploratory manner. in humans: YIPF1, YIPF2, YIPF3, YIPF4, Patients evaluated throughout the Unit- It is helpful to define a specific pheno- YIPF5, YIPF6, and YIPF7 (27). YIPF5 is ed Kingdom and worldwide undergo type, study multiple affected individuals, located in the early Golgi intermediate next-generation sequencing on a grow- and suspect a specific inheritance pat- compartment (ERGIC) and is viewed as the ing panel currently containing 71 known tern. In De Franco and Lytrivi et al. (20), ortholog of yeast Yip1p (28). YIPF5-con- or putative monogenic diabetes genes, the authors met these requirements by taining complexes are believed to play a where a subset is analyzed guided by sequencing two unrelated individuals critical role in trafficking of COPII-coated clinical information. A well-curated list with the specific constellation of neonatal vesicles from the ER to the cis-Golgi (27). of these genes is provided on the Diabe- diabetes, seizures, and severe microceph- Other YIPF family members are found in tesGenes website (https://www.diabetes- aly. Both were born to first-cousin pairs, characteristic locations in the ER or Golgi genes.org/). This diagnostic program is increasing the likelihood of autosomal and are also believed to function in vesicle currently the most cost-effective method recessive inheritance due to homozy- transport (27, 29). for achieving a clinical genetic diagnosis gous inheritance in each case of a vari- Proinsulin is synthesized by ribosomes and optimally captures the specific genes ant shared by the related parents. This in the rough ER and transported through involved. However, this routine approach approach allowed
Load more

Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Fine Mapping of the Hereditary Haemorrhagic Telangiectasia (HHT)3 Locus on Chromosome 5 Excludes VE-Cadherin-2, Sprouty4 And
    Govani and Shovlin Journal of Angiogenesis Research 2010, 2:15 http://www.jangiogenesis.com/content/2/1/15 JOURNAL OF ANGIOGENESIS RESEARCH RESEARCH Open Access Fine mapping of the hereditary haemorrhagic telangiectasia (HHT)3 locus on chromosome 5 excludes VE-Cadherin-2, Sprouty4 and other interval genes Fatima S Govani, Claire L Shovlin* Abstract Background: There is significant interest in new loci for the inherited condition hereditary haemorrhagic telangiectasia (HHT) because the known disease genes encode proteins involved in vascular transforming growth factor (TGF)-b signalling pathways, and the disease phenotype appears to be unmasked or provoked by angiogenesis in man and animal models. In a previous study, we mapped a new locus for HHT (HHT3) to a 5.7 Mb region of chromosome 5. Some of the polymorphic markers used had been uninformative in key recombinant individuals, leaving two potentially excludable regions, one of which contained loci for attractive candidate genes encoding VE Cadherin-2, Sprouty4 and FGF1, proteins involved in angiogenesis. Methods: Extended analyses in the interval-defining pedigree were performed using informative genomic sequence variants identified during candidate gene sequencing. These variants were amplified by polymerase chain reaction; sequenced on an ABI 3730xl, and analysed using FinchTV V1.4.0 software. Results: Informative genomic sequence variants were used to construct haplotypes permitting more precise citing of recombination breakpoints. These reduced the uninformative centromeric region from 141.2-144 Mb to between 141.9-142.6 Mb, and the uninformative telomeric region from 145.2-146.9 Mb to between 146.1-146.4 Mb. Conclusions: The HHT3 interval on chromosome 5 was reduced to 4.5 Mb excluding 30% of the coding genes in the original HHT3 interval.
    [Show full text]
  • RNA Editing at Baseline and Following Endoplasmic Reticulum Stress
    RNA Editing at Baseline and Following Endoplasmic Reticulum Stress By Allison Leigh Richards A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Human Genetics) in The University of Michigan 2015 Doctoral Committee: Professor Vivian G. Cheung, Chair Assistant Professor Santhi K. Ganesh Professor David Ginsburg Professor Daniel J. Klionsky Dedication To my father, mother, and Matt without whom I would never have made it ii Acknowledgements Thank you first and foremost to my dissertation mentor, Dr. Vivian Cheung. I have learned so much from you over the past several years including presentation skills such as never sighing and never saying “as you can see…” You have taught me how to think outside the box and how to create and explain my story to others. I would not be where I am today without your help and guidance. Thank you to the members of my dissertation committee (Drs. Santhi Ganesh, David Ginsburg and Daniel Klionsky) for all of your advice and support. I would also like to thank the entire Human Genetics Program, and especially JoAnn Sekiguchi and Karen Grahl, for welcoming me to the University of Michigan and making my transition so much easier. Thank you to Michael Boehnke and the Genome Science Training Program for supporting my work. A very special thank you to all of the members of the Cheung lab, past and present. Thank you to Xiaorong Wang for all of your help from the bench to advice on my career. Thank you to Zhengwei Zhu who has helped me immensely throughout my thesis even through my panic.
    [Show full text]
  • Variation in Protein Coding Genes Identifies Information
    bioRxiv preprint doi: https://doi.org/10.1101/679456; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Animal complexity and information flow 1 1 2 3 4 5 Variation in protein coding genes identifies information flow as a contributor to 6 animal complexity 7 8 Jack Dean, Daniela Lopes Cardoso and Colin Sharpe* 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Institute of Biological and Biomedical Sciences 25 School of Biological Science 26 University of Portsmouth, 27 Portsmouth, UK 28 PO16 7YH 29 30 * Author for correspondence 31 [email protected] 32 33 Orcid numbers: 34 DLC: 0000-0003-2683-1745 35 CS: 0000-0002-5022-0840 36 37 38 39 40 41 42 43 44 45 46 47 48 49 Abstract bioRxiv preprint doi: https://doi.org/10.1101/679456; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Animal complexity and information flow 2 1 Across the metazoans there is a trend towards greater organismal complexity. How 2 complexity is generated, however, is uncertain. Since C.elegans and humans have 3 approximately the same number of genes, the explanation will depend on how genes are 4 used, rather than their absolute number.
    [Show full text]
  • Nuclear PTEN Safeguards Pre-Mrna Splicing to Link Golgi Apparatus for Its Tumor Suppressive Role
    ARTICLE DOI: 10.1038/s41467-018-04760-1 OPEN Nuclear PTEN safeguards pre-mRNA splicing to link Golgi apparatus for its tumor suppressive role Shao-Ming Shen1, Yan Ji2, Cheng Zhang1, Shuang-Shu Dong2, Shuo Yang1, Zhong Xiong1, Meng-Kai Ge1, Yun Yu1, Li Xia1, Meng Guo1, Jin-Ke Cheng3, Jun-Ling Liu1,3, Jian-Xiu Yu1,3 & Guo-Qiang Chen1 Dysregulation of pre-mRNA alternative splicing (AS) is closely associated with cancers. However, the relationships between the AS and classic oncogenes/tumor suppressors are 1234567890():,; largely unknown. Here we show that the deletion of tumor suppressor PTEN alters pre-mRNA splicing in a phosphatase-independent manner, and identify 262 PTEN-regulated AS events in 293T cells by RNA sequencing, which are associated with significant worse outcome of cancer patients. Based on these findings, we report that nuclear PTEN interacts with the splicing machinery, spliceosome, to regulate its assembly and pre-mRNA splicing. We also identify a new exon 2b in GOLGA2 transcript and the exon exclusion contributes to PTEN knockdown-induced tumorigenesis by promoting dramatic Golgi extension and secretion, and PTEN depletion significantly sensitizes cancer cells to secretion inhibitors brefeldin A and golgicide A. Our results suggest that Golgi secretion inhibitors alone or in combination with PI3K/Akt kinase inhibitors may be therapeutically useful for PTEN-deficient cancers. 1 Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai 200025, China. 2 Institute of Health Sciences, Shanghai Institutes for Biological Sciences of Chinese Academy of Sciences and SJTU-SM, Shanghai 200025, China.
    [Show full text]
  • Appendix 2. Significantly Differentially Regulated Genes in Term Compared with Second Trimester Amniotic Fluid Supernatant
    Appendix 2. Significantly Differentially Regulated Genes in Term Compared With Second Trimester Amniotic Fluid Supernatant Fold Change in term vs second trimester Amniotic Affymetrix Duplicate Fluid Probe ID probes Symbol Entrez Gene Name 1019.9 217059_at D MUC7 mucin 7, secreted 424.5 211735_x_at D SFTPC surfactant protein C 416.2 206835_at STATH statherin 363.4 214387_x_at D SFTPC surfactant protein C 295.5 205982_x_at D SFTPC surfactant protein C 288.7 1553454_at RPTN repetin solute carrier family 34 (sodium 251.3 204124_at SLC34A2 phosphate), member 2 238.9 206786_at HTN3 histatin 3 161.5 220191_at GKN1 gastrokine 1 152.7 223678_s_at D SFTPA2 surfactant protein A2 130.9 207430_s_at D MSMB microseminoprotein, beta- 99.0 214199_at SFTPD surfactant protein D major histocompatibility complex, class II, 96.5 210982_s_at D HLA-DRA DR alpha 96.5 221133_s_at D CLDN18 claudin 18 94.4 238222_at GKN2 gastrokine 2 93.7 1557961_s_at D LOC100127983 uncharacterized LOC100127983 93.1 229584_at LRRK2 leucine-rich repeat kinase 2 HOXD cluster antisense RNA 1 (non- 88.6 242042_s_at D HOXD-AS1 protein coding) 86.0 205569_at LAMP3 lysosomal-associated membrane protein 3 85.4 232698_at BPIFB2 BPI fold containing family B, member 2 84.4 205979_at SCGB2A1 secretoglobin, family 2A, member 1 84.3 230469_at RTKN2 rhotekin 2 82.2 204130_at HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 81.9 222242_s_at KLK5 kallikrein-related peptidase 5 77.0 237281_at AKAP14 A kinase (PRKA) anchor protein 14 76.7 1553602_at MUCL1 mucin-like 1 76.3 216359_at D MUC7 mucin 7,
    [Show full text]
  • 17 - 19 October 2019
    THE 12TH INTERNATIONAL SYMPOSIUM ON HEALTH INFORMATICS AND BIOINFORMATICS T G T A A A T G A G A A G T T G G G T A A A A A A A A T T T A A A A A A G G A A A A A A A G G G G G G G G A A A G G G G G G T T G G G G G G G T T T T G G T T G G G T T T G G T A A T T G G T T T A A A A A A A A T T T A A A A A A T T A A A A A A A T A T T T T T T A A A T T T T G T A G A A T T T A A 17 - 19 OCTOBER 2019 HIBIT 2019 ABSTRACT BOOK THE 12TH INTERNATIONAL SYMPOSIUM ON HEALTH INFORMATICS AND BIOINFORMATICS TABLE OF CONTENTS 1 8 WELCOME MESSAGE KEYNOTE LECTURERS 2 19 ORGANIZING COMMITEE INVITED SPEAKERS 3 29 SCIENTIFIC COMMITEE SELECTED ABSTRACTS FOR ORAL PRESENTATIONS 6 61 PROGRAM POSTER PRESENTATIONS Welcome Message The International Symposium on Health Informatics and Bioinformatics, (HIBIT), now in its twelfth year HIBIT 2019, aims to bring together academics, researchers and practitioners who work in these popular and fulfilling areas and to create the much- needed synergy among medical, biological and information technology sectors. HIBIT is one of the few conferences emphasizing such synergy.
    [Show full text]
  • Unique Networks: a Method to Identify Disease-Specific Regulatory Networks from Microarray Data
    UNIQUE NETWORKS: A METHOD TO IDENTIFY DISEASE-SPECIFIC REGULATORY NETWORKS FROM MICROARRAY DATA A thesis submitted for the degree of Doctor of Philosophy by Valeria Bo Department of Computer Science December 2014 Abstract The survival of any organism is determined by the mechanisms triggered in response to the inputs received. Underlying mechanisms are described by graphical networks that can be inferred from different types of data such as microarrays. Deriving robust and reliable networks can be complicated due to the microarray structure of the data characterized by a discrepancy between the number of genes and samples of several orders of magnitude, bias and noise. Researchers overcome this problem by integrating independent data together and deriving the common mechanisms through consensus network analysis. Different conditions generate different inputs to the organism which reacts triggering different mechanisms with similarities and differences. A lot of effort has been spent into identifying the commonalities under different conditions. Highlighting similarities may overshadow the differences which often identify the main characteristics of the triggered mechanisms. In this thesis we introduce the concept of study-specific mechanism. We develop a pipeline to semi- automatically identify study-specific networks called unique-networks through a combination of consensus approach, graphical similarities and network analysis. The main pipeline called UNIP (Unique Networks Identification Pipeline) takes a set of independent studies, builds gene regulatory networks for each of them, calculates an adapta- tion of the sensitivity measure based on the networks graphical similarities, applies clustering to group the studies who generate the most similar networks into study-clusters and derives the consensus networks.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Rattlesnake Genome Supplemental Materials 1 SUPPLEMENTAL
    Rattlesnake Genome Supplemental Materials 1 1 SUPPLEMENTAL MATERIALS 2 Table of Contents 3 1. Supplementary Methods …… 2 4 2. Supplemental Tables ……….. 23 5 3. Supplemental Figures ………. 37 Rattlesnake Genome Supplemental Materials 2 6 1. SUPPLEMENTARY METHODS 7 Prairie Rattlesnake Genome Sequencing and Assembly 8 A male Prairie Rattlesnake (Crotalus viridis viridis) collected from a wild population in Colorado was 9 used to generate the genome sequence. This specimen was collected and humanely euthanized according 10 to University of Northern Colorado Institutional Animal Care and Use Committee protocols 0901C-SM- 11 MLChick-12 and 1302D-SM-S-16. Colorado Parks and Wildlife scientific collecting license 12HP974 12 issued to S.P. Mackessy authorized collection of the animal. Genomic DNA was extracted using a 13 standard Phenol-Chloroform-Isoamyl alcohol extraction from liver tissue that was snap frozen in liquid 14 nitrogen. Multiple short-read sequencing libraries were prepared and sequenced on various platforms, 15 including 50bp single-end and 150bp paired-end reads on an Illumina GAII, 100bp paired-end reads on an 16 Illumina HiSeq, and 300bp paired-end reads on an Illumina MiSeq. Long insert libraries were also 17 constructed by and sequenced on the PacBio platform. Finally, we constructed two sets of mate-pair 18 libraries using an Illumina Nextera Mate Pair kit, with insert sizes of 3-5 kb and 6-8 kb, respectively. 19 These were sequenced on two Illumina HiSeq lanes with 150bp paired-end sequencing reads. Short and 20 long read data were used to assemble the previous genome assembly version CroVir2.0 (NCBI accession 21 SAMN07738522).
    [Show full text]
  • The Ultimated Edition to the Mountdomain
    THEULTIMATED EDITIONUS 20170247762A1 TO THE MOUNTDOMAIN ( 19) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2017/ 0247762 A1 Heiman ( 43 ) Pub . Date: Aug . 31 , 2017 ( 54 ) COMPOSITIONS , METHODS AND USE OF Publication Classification SYNTHETIC LETHAL SCREENING (51 ) Int . CI. C120 1 /68 ( 2006 . 01 ) (71 ) Applicants : THE BOARD INSTITUTE INC ., C12N 15 / 113 ( 2006 .01 ) Cambridge, MA (US ) ; Massachusetts COZK 16 / 40 ( 2006 .01 ) Institute of Technology , Cambridge , A01K 67 /027 (2006 . 01 ) C12N 9 / 22 ( 2006 . 01 ) MA (US ) (52 ) U . S . CI. CPC . .. C12Q 1 /6883 (2013 . 01) ; A01K 67 /0278 (72 ) Inventor : Myriam Heiman , Newton , MA (US ) ( 2013 .01 ) ; C12N 9 / 22 ( 2013 .01 ) ; CO7K 16 / 40 ( 2013 .01 ) ; C12Y 111 /01009 ( 2013 . 01 ) ; C12N (21 ) Appl. No. : 15 /521 , 780 15 / 113 (2013 .01 ) ; AOIK 2267 / 0318 ( 2013 .01 ) ; C12Q 2600 / 118 ( 2013 . 01 ) ; C12Q 2600 / 158 (22 ) PCT Filed : Oct . 27 , 2015 (2013 .01 ) ; C120 2600 / 136 (2013 .01 ) ; C12N ( 86 ) PCT No. : PCT/ US2015 / 057567 2310 / 20 ( 2017 .05 ) ; CO7K 2317 / 34 (2013 .01 ) $ 371 ( C ) ( 1 ), (57 ) ABSTRACT Apr. 25 , 2017 The present invention generally relates to methods of iden ( 2 ) Date : tifying modulators of central nervous system diseases and the use of the modulators in treatment and diagnosis . The methods utilize a novel high throughput screen that includes Related U . S . Application Data injection of a library of barcoded viral vectors expressing (60 ) Provisional application No . 62/ 122, 686 , filed on Oct. shRNA ' s , CRISPR / Cas systems or cDNA ' s into animal 27 , 2014 . models of disease and detecting synthetic lethality .
    [Show full text]
  • Genomic Diagnostics Within a Medically Underserved Population: Efficacy and Implications
    © American College of Medical Genetics and Genomics ORIGINAL RESEARCH ARTICLE Genomic diagnostics within a medically underserved population: efficacy and implications Kevin A. Strauss, MD1, Claudia Gonzaga-Jauregui, PhD2, Karlla W. Brigatti, MS1, Katie B. Williams, MD, PhD1, Alejandra K. King, PhD2, Cristopher Van Hout, PhD2, Donna L. Robinson, CRNP1, Millie Young, RNC1, Kavita Praveen, PhD2, Adam D. Heaps, MS1, Mindy Kuebler, MS1, Aris Baras, MD2, Jeffrey G. Reid, PhD2, John D. Overton, PhD2, Frederick E. Dewey, MD2, Robert N. Jinks, PhD3, Ian Finnegan, BA3, Scott J. Mellis, MD, PhD2, Alan R. Shuldiner, MD2 and Erik G. Puffenberger, PhD1 Purpose: We integrated whole-exome sequencing (WES) and Compared to trio analysis, “family” WES (average seven exomes chromosomal microarray analysis (CMA) into a clinical workflow per proband) reduced filtered candidate variants from 22 ± 6to to serve an endogamous, uninsured, agrarian community. 5 ± 3 per proband. Nineteen (51%) alleles were de novo and 17 Methods: Seventy-nine probands (newborn to 49.8 years) who (46%) inherited; the latter added to a population-based diagnostic presented between 1998 and 2015 remained undiagnosed after panel. We found actionable secondary variants in 21 (4.2%) of 502 biochemical and molecular investigations. We generated WES data subjects, all of whom opted to be informed. for probands and family members and vetted variants through Conclusion: CMA and family-based WES streamline and rephenotyping, segregation analyses, and population studies. economize diagnosis of rare genetic disorders, accelerate novel Results: The most common presentation was neurological disease gene discovery, and create new opportunities for community-based (64%). Seven (9%) probands were diagnosed by CMA.
    [Show full text]